Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e64-e66. doi: 10.1111/jdv.15914. Epub 2019 Sep 12.

Authors

A N Voorberg¹, W F A den Dunnen², R H J Wijdh³, M S de Bruin-Weller⁴, M L A Schuttelaar¹

Affiliations

¹ Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
² Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
³ Department of Ophthalmology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
⁴ Department of Dermatology, University Medical Center Utrecht, Utrecht, The Netherlands.

PMID: 31465590
DOI: 10.1111/jdv.15914

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / pharmacology
Conjunctiva / drug effects*
Conjunctiva / pathology
Conjunctivitis / chemically induced*
Conjunctivitis / pathology*
Dermatitis, Atopic / drug therapy
Female
Goblet Cells / pathology*
Humans
Interleukin-4 Receptor alpha Subunit / drug effects*

Substances

Antibodies, Monoclonal, Humanized
Interleukin-4 Receptor alpha Subunit
dupilumab